VNRX — VOLITIONRX LTD

—
NYSE · Health Care · Life Sciences Tools & Services · CIK 93314 ·
Last close
$0.19
Market Cap
$6.81M
52W High
$7.80
52W Low
$0.16
ADV30
3,073,072
Next earnings
2026-11-12
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 398,657 — -4,201,897 -7,326,047 8,300,986 2,790,994 41,840,346
Mar 2026 985,076 — -5,228,321 -6,664,774 9,036,483 3,102,817 42,396,412
Dec 2025 447,034 — -4,731,280 -6,270,832 6,901,227 1,117,028 42,494,038
Sep 2025 627,277 — -4,868,806 -5,378,358 6,448,885 199,407 42,398,447

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-19,562,408
Investing CF
$-21,969
Financing CF
$20,350,966
CapEx
$-98,752
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.04
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-267,352,291
Inventory
—
Receivables
$277,355
ST Investments
—
EBIT TTM
$-22,066,011
Pretax Income TTM
$-25,731,452
Interest Exp TTM
$3,665,441
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,458,044
EBITDA
$-18,572,584
Free Cash Flow
$-9,213,488
Enterprise Value
$9,763,200
Total Cash
$2,790,994
Total Debt
$11,410,300
Shares Out
36,082,903
Trailing EPS
$-3.80
Book Value
$-5.45
ROE
—
ROA
-142.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,727,384 -21,222,056 -23,357,027 6,901,227 42,494,038 -34,246,393 -19,683,334
Dec 2024 1,233,511 -26,921,602 -26,967,836 9,399,523 35,507,259 -24,907,620 -25,893,624
Dec 2023 775,302 -35,773,244 -35,319,078 27,950,498 36,662,720 -7,802,255 -18,062,999
Dec 2022 306,392 -30,550,647 -30,268,793 18,295,054 21,422,016 -2,574,991 -15,277,742

TTM Snapshot

Revenues TTM
$2,458,044
NetIncome TTM
$-25,640,011
OpCashFlow TTM
—
Assets (Latest)
$8,300,986
Forward EPS
$-0.85

Peers — same industry

TickerNameMarket CapLastDaily %
AWHL Aspira Women's Health Inc. $7.00M $0.15 —
BMRA BIOMERICA INC $5.68M $1.24 —
CDIO Cardio Diagnostics Holdings, Inc. $5.06M $1.71 —
TRIB TRINITY BIOTECH PLC $4.89M $6.01 —
VSBC VITASPRING BIOMEDICAL CO. LTD. $3.21M $0.02 —

News headlines (Yahoo Finance, 1h cache)

VolitionRx Highlights a Transformational Year: Clinical Validation, Commercial Partnerships, and Potential Upcoming Milestones
2026-11-17 14:31 · Yahoo
Volition Expands Contract with Fujifilm to Include the Nu.Q® Vet Test for Cats
2026-11-16 21:22 · Yahoo
VolitionRx (VNRX) Q3 2026 Earnings Call Transcript
2026-11-13 19:28 · Yahoo
VolitionRx Limited Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
VolitionRX: Q3 Earnings Snapshot
2026-11-12 21:41 · Yahoo
VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update
2026-11-12 21:10 · Yahoo
VolitionRx Limited Schedules Third Quarter 2026 Earnings Conference Call and Business Update
2026-11-09 21:10 · Yahoo
VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
2026-10-27 12:47 · Yahoo
VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
2026-10-27 12:17 · Yahoo
VolitionRx Participates in Launch of DETECSEPS Program in France
2026-09-17 12:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.